The Forbes Healthcare Summit 2018: The Draft Agenda

By | November 15, 2018
Louis J. DeGennaro,  president & chief executive officer, The Leukemia & Lymphoma Society  (LLS),  interviews patient advocates Austin, Kimberly & Jeffrey Schuetz about CAR-T therapy at the 2017 Health Care Summit.

Louis J. DeGennaro, president & chief executive officer, The Leukemia & Lymphoma Society (LLS), interviews patient advocates Austin, Kimberly & Jeffrey Schuetz about CAR-T therapy at the 2017 Health Care Summit.Forbes

We’re two weeks away from the big event. On November 28, we’ll host the Forbes Healthcare Summit, a 24-hour meeting (time off for sleep) of the top executives from the pharmaceutical, insurance and hospital sectors. Among the highlights this year: deep, multipart looks at drug pricing and mergers and acquisitions, as well as a master course in building a biotechnology firm and a visit with some health care experts who have had to experience the healthcare system as caregivers. There’s still some space available, and you can apply for an invite by emailing healthcare@forbes.com or by clicking on this link. I hope to see you there!

*All sessions subject to change

Wednesday, November 28

4:30pm Registration

5:00pm Welcome         

5:05pm  A Venture Legend Gets Health John Doerr is the guy who backed Google, Amazon and Uber. Now he’s interested in healthcare. Hear his thoughts on the disruption to come.

  • John Doerr, Chairman, Kleiner Perkins
  • Interviewer: Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media

5:35pm The Future of Pharmacy and Healthcare  Stefano Pessina, the man behind the Walgreens Boots Alliance, joins us once again to share how his vision of drugstores is adapting to changing markets and changing customer behavior.

  • Stefano Pessina, Executive Vice Chairman & Chief Executive Officer, Walgreens Boots Alliance
  • Interviewer: Moira Forbes, Executive Vice President, Forbes Media

6:00pm   Cocktail Reception Brought To You By Sanofi  (Ertegun Atrium)

Thursday, November 29

8:00am Welcome (Appel Room)

Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media

8:05am Opening Remarks

Steve Forbes, Chairman & Editor-in-Chief, Forbes Media

8:15am Novartis Now It’s been a busy first year for Novartis CEO Vas Narasimhan. He’s made big bets on gene therapy, digital health and cancer drugs that work by dosing radiation. But it hasn’t all been smooth sailing. He’s here to tell us about his plans for the future.

  • Vas Narasimhan, M.D., Chief Executive Officer, Novartis
  • Interviewer: Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media

8:35am  Spotlight: How My Health Scare Led to a New Treatment Surbhi Sarna’s painful teenage experience with an ovarian cyst led her to found a company that developed a device for diagnosing ovarian cancer. Boston Scientific purchased it for $ 275 million. She tells her story.

  • Surbhi Sarna, Founder & Chief Executive Officer, nVision Medical

8:40am Is Drug Pricing Being Disrupted? Everyone from the White House to the pharmacy counter seems to think change is coming. Is it?

  •    Steve Miller, Senior Vice President & Chief Medical Officer, Express Scripts
  • Stephen Ubl, Chief Executive Officer, PhRMA
  • Moderator: Avik Roy, President, The Foundation for Research on Equal Opportunity; Opinion Editor, Forbes Media

9:00am Mega-Merger Mania The healthcare industry has been on a merger tear. Is the recent run of deals an unhealthy craze promulgated by the shift to value-based care and changing compensation models? Hear from the leaders who are driving the deals to revamp healthcare as we know it.

Part I: Why Is A Drugstore Buying A Health Insurer?

CVS Health used to be a neighborhood pharmacy. Then it moved into the business of managing prescription drug insurance plans. Now? It’s buying Aetna, the insurer. What is the goal of this expansion?

  • Larry Merlo, Chairman & Chief Executive Officer, CVS Health    
  • Interviewer: Michael Noer, Executive Editor, Forbes Media

9:20am Part II: The Largest-Ever Foreign Takeover by a Japanese Company Takeda was already in the midst of engineering a reinvention of its research laboratories. Now, it plans to supercharge that effort with the $ 62 billion purchase of rival Shire. Here’s the plan.

  • Christophe Weber, President & Chief Executive Officer, Takeda Pharmaceutical Company
  • Interviewer: John LaMattina, Senior Partner, PureTech Health

9:35am Health Beyond Healthcare Healthcare is not just about prescribing drugs or performing surgery. Food, transportation, and living environment can matter just as much as medicine. Insurers and healthcare systems are waking up to this reality.

Healthcare Is About Buildings And Food

  • Bruce Broussard, Chief Executive Officer, Humana
  • Barry Ostrowsky, President and Chief Executive Officer, RWJBarnabas Health
  • Moderator: Bruce Japsen, Healthcare Contributor, Forbes Media

9:55am From DNA Code to Zip Code

  • Michael Dowling, President & Chief Executive Officer, Northwell Health
  • Jaewon Ryu, MD, JD, Executive Vice President and Chief Medical Officer, Geisinger
  • Moderator: Moira Forbes, Executive Vice President, Forbes Media

10:15am Morning Break (Ertegun Atrium)

10:45am Spotlight: Watching Discoveries Grow (Appel Room) Cigall Kadoch was a grad student when she first started studying a gene linked to a rare cancer. Now she’s a 33-year-old professor with a $ 50 million startup. She tells her story.

  • Cigall Kadoch, Assistant Professor, Dana-Farber Cancer Institute; Cofounder, Foghorn Therapeutics  

10:50am From Zero to Breakthrough In the biotechnology business change happens fast. Decades of burning cash can be reversed by a single important product. Pharmaceutical research is famously expensive and wasteful. Yet we are in a time when more and more real advances are being developed to help patients. Here, we take stock.

  • Doug Ingram, President & Chief Executive Officer, Sarepta Therapeutics
  • Jeff Jonas, M.D., Chief Executive Officer, Sage Therapeutics
  • Jeffrey Leiden, Chief Executive Officer, Vertex Pharmaceuticals
  • John Maraganore, Chief Executive Officer, Alnylam Pharmaceuticals
  • Moderator: Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media

11:25am Special Session

11:45am Spotlight

11:50am Why I’m Trying to Change Drug Pricing Through his philanthropy, energy billionaire John Arnold has become a major force in the conversation about drug prices. He joins us to explain why.  

  • John Arnold, Co-Chair, Laura and John Arnold Foundation
  • Moderator: Matthew Herper, Senior Editor, Pharma & Healthcare, Forbes Media

12:15pm Lunch Brought To You By Wells Fargo (Ertegun Atrium)

1:25pm Afternoon Welcome  (Appel Room)

  • Steve Forbes, Chairman & Editor-in-Chief, Forbes Media

1:30pm Why Patient Data Is Changing Everything Forget money, drug targets or even executives. Access to high-quality data about patients has become the most important asset in the healthcare business.

  • Sam Marwaha, Senior Partner and Managing Director, BCG

1:35pm The Patient Data Revolution Medicine has had to do without the access to big datasets that are so important in other industries. But a group of young companies are changing that in a big way. Find out what big data means when we’re talking about patients.

  • Nat Turner, Cofounder and Chief Executive Officer, Flatiron Health
  • Moderator: Ellie Kincaid, Assistant Editor, Healthcare, Forbes Media

1:55pm How Smart Is Artificial Intelligence AI is becoming a buzzword. But beyond the hype and headlines, this technology has the potential to change healthcare. We take a look.

  • Jennifer Esposito, Worldwide General Manager, Health and Life Sciences Group, Intel Corporation
  • Robert Nelsen, Cofounder & Managing Director, ARCH Venture Partners
  • Joanna Shields, Chief Executive, Benevolent AI
  • Moderator: Colin Hill, Chief Executive Officer, Chairman & Cofounder, GNS Healthcare

2:30pm Special Onstage Interview

2:50pm Spotlight: It’s Time to Talk About Dying More terminal patients are placing their private, personal journeys in the public domain. Michael Becker, a former C-level industry executive with over 25 years of life sciences experience, tells his story of finding purpose even while facing life’s final, great event.

  • Michael D. Becker, President & Founder, MDB Communications

2:55pm Healthcare From the Outside In Lucy Kalanithi is a doctor who understands what it means to be a patient. Her husband, Paul Kalanithi, wrote the bestseller When Breath Becomes Air as he died from lung cancer. These other panelists, too, are experts who have had to face the system as caregivers. Here is what they have learned.

  • Peter B. Bach, MD, MAPP, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
  • Lucy Kalanithi, Clinical Assistant Professor of Medicine, Stanford University School of Medicine
  • Christi Shaw, Senior Vice President, Eli Lilly and Company, and President, Lilly Bio-Medicines
  • Moderator: Julie Grant, Partner, Canaan Partners

3:30pm Afternoon Break (Ertegun Atrium)

3:55 pm Spotlight

4:00pm Can We End Cancer? (Appel Room) Breakthroughs in immunotherapy and genetics are leading to amazingly effective cancer drugs. How far can this research take us?

  • Joshua H. Bilenker, M.D., President and Chief Executive Officer, Loxo Oncology
  • David Chang, M.D., Ph.D., President, Chief Executive Officer and Cofounder, Allogene Therapeutics
  • Roger M. Perlmutter, M.D., Ph.D., Executive Vice President & President, Merck Research Laboratories

4:35pm Spotlight: The Synthetic Biology Revolution Gingko Bioworks wants to use biology to revolutionize all industries. Here’s a look at what genetic engineering can do.

  • Reshma Shetty, Cofounder, Ginkgo Bioworks

4:40pm Big Solutions to Big Problems Plenty of people are ready to criticize Big Pharma. But the industry is winning stirring victories against cancer, hepatitis C and cardiovascular disease. Here it’s leaders engage with an eye toward solving large societal issues.

  • Giovanni Caforio, Chief Executive Officer, Bristol-Myers Squibb
  • Daniel O’Day, Chief Executive Officer, Roche Pharmaceuticals
  • Moderator: Steve Forbes, Chairman & Editor-in-Chief, Forbes Media

5:00pm Closing Remarks

Health|HealthCare – Google News